{"title":"Contents in Brief","authors":"","doi":"10.1016/S1051-0443(25)00547-0","DOIUrl":"10.1016/S1051-0443(25)00547-0","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 10","pages":"Page A4"},"PeriodicalIF":2.6,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sean P. Duminie MD , Courtney E. Morgan MD , Sean K. Golden MD
{"title":"Lessons in IR: Chylothorax as an Adverse Event of Thoracic Duct Embolization","authors":"Sean P. Duminie MD , Courtney E. Morgan MD , Sean K. Golden MD","doi":"10.1016/j.jvir.2025.06.015","DOIUrl":"10.1016/j.jvir.2025.06.015","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 10","pages":"Pages 1632-1633"},"PeriodicalIF":2.6,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D A F van den Heuvel, S Klompmaker, J Hessels, A D Diederik, J J Mager, J C van den Berg, M C Post
{"title":"Pulmonary Arteriovenous Malformation embolization: The role of Contrast-Enhanced Computed Tomography and Standardized Outcome Measures.","authors":"D A F van den Heuvel, S Klompmaker, J Hessels, A D Diederik, J J Mager, J C van den Berg, M C Post","doi":"10.1016/j.jvir.2025.09.024","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.09.024","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the pulmonary arteriovenous malformation (PAVM) persistence rate in patients treated with microcoils, vascular plugs, or a combination of these, and to propose standardized outcome criteria using contrast-enhanced computed tomography (CECT).</p><p><strong>Materials and methods: </strong>This retrospective study included all adult patients undergoing embolization of de novo PAVMs using micro-coils and/or Amplatzer type I vascular plugs (AVP-I), between 2005 and 2012. PAVM persistence was assessed at 6 months using CECT, focussing on vein enhancement vs shrinkage rates. Endpoints were overall persistence and persistence in technically successful treated de novo PAVMs. This was defined as confirmed occlusion of all embolized feeding arteries, embolization ≤10 mm of the sac and without missed feeding arteries.</p><p><strong>Results: </strong>The study included 113 patients (mean age 42±18 years, 63 female) representing 292 PAVMs for analysis. Persistence was observed in 82 of 292 (28%) PAVMs and was angiographically confirmed in all cases. Of the persistent PAVMs, 16% showed >70% sac shrinkage on CECT. Among 108 technically successful treated simple PAVMs, overall persistence was 11% (7% for AVP-I and 21% for coils).</p><p><strong>Conclusion: </strong>Based on CECT and with angiographical confirmation, overall PAVM persistence at 6 months after embolization with coils or AVPs was 28%. A suspected high sensitivity of CECT for detecting PAVM persistence may partially account for outcome differences compared to previous studies and underscores the need for standardized imaging and reporting protocols.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonios Michailidis, Panagiotis Kosmoliaptsis, Danae Makri, George Dimou, Evangelos N Symeonidis, Andreas Andreou, Stylianos Tegos, Apostolos Papalakis, Panagiotis Mpalaksis, Georgios Moustakas, Christos Giankoulof, Evangelos Petsatodis
{"title":"Percutaneous Cryoablation of T1b Renal Tumors: A Retrospective Evaluation of Local Tumor Control, Renal Function Preservation, Adverse Events and Ablation Margins in 80 Patients.","authors":"Antonios Michailidis, Panagiotis Kosmoliaptsis, Danae Makri, George Dimou, Evangelos N Symeonidis, Andreas Andreou, Stylianos Tegos, Apostolos Papalakis, Panagiotis Mpalaksis, Georgios Moustakas, Christos Giankoulof, Evangelos Petsatodis","doi":"10.1016/j.jvir.2025.09.025","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.09.025","url":null,"abstract":"<p><strong>Purpose: </strong>This retrospective study investigates the long-term efficacy and safety of percutaneous cryoablation (PCA) for the treatment of clinical T1b renal masses (RMs) over a minimum follow-up of two years. The primary hypothesis is that achieving an intraprocedural ice-ball margin of ≥8 mm during PCA of T1b renal cell carcinoma (RCC) results in superior local tumor control without increasing adverse events.</p><p><strong>Materials and methods: </strong>Eighty consecutive patients with biopsy-proven T1b RCC (tumor size 4.1-7.0 cm) were treated with CT-guided PCA between 2019 and 2023 at a single center. Outcomes assessed included local tumor progression-free survival (LTPFS), change in renal function (eGFR), and adverse events per Society of Interventional Radiology (SIR) criteria. Ice-ball margins were categorized as <8 mm versus ≥8 mm. Kaplan-Meier survival curves and log-rank tests were used for statistical analysis, with significance set at p < 0.05.</p><p><strong>Results: </strong>Primary efficacy was 95% (76/80), while secondary efficacy reached 98.8% (79/80) after retreatment of four local recurrences. The 24-month LTPFS was 98.8%. Patients with an ice-ball margin ≥8 mm showed superior 24-month local control (100%) compared to those with 5-<8 mm margins (57% at 6 months; p = 0.002). Mean eGFR declined slightly by -2 mL/min/1.73 m<sup>2</sup> (p = 0.125). No SIR Grade 3 or higher adverse events reported.</p><p><strong>Conclusion: </strong>PCA is a safe, effective, and nephron-sparing treatment for T1b RCC. Achieving an ice-ball margin ≥8 mm significantly reduces residual disease and early recurrence.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
William M Kamp, Maggie X Xiong, Mohammad Khavandi, Rahul Sheth, Mohammad Abdelsalam, Nariman Nezami, Alda Tam, Steven Huang, Peiman Habibollahi
{"title":"Safety and Effectiveness of Adrenal Cryoablation for Patients with Melanoma Metastases on Concurrent Targeted Therapy or Immunotherapy.","authors":"William M Kamp, Maggie X Xiong, Mohammad Khavandi, Rahul Sheth, Mohammad Abdelsalam, Nariman Nezami, Alda Tam, Steven Huang, Peiman Habibollahi","doi":"10.1016/j.jvir.2025.09.022","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.09.022","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Authors' Reply: Histopathologic Outcomes after TACE and TARE.","authors":"Alex Sher, Edward Kim","doi":"10.1016/j.jvir.2025.09.023","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.09.023","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Histopathologic Response and Oncologic Outcomes after TACE and TARE for HCC: Selection Bias and Suboptimal Technique Are Better Explanations.","authors":"Sameer Bhatia","doi":"10.1016/j.jvir.2025.08.046","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.08.046","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Go Shirota, So Sato, Hideo Yasunaga, Yuichiro Matsuo, Masaaki Akahane, Daisuke Itoh, Osamu Abe
{"title":"Cost-effectiveness of Preventive Transarterial Embolization for Splenic Artery Aneurysm Below the Guideline-Recommended Size Threshold: A Japanese Claims-Based Study.","authors":"Go Shirota, So Sato, Hideo Yasunaga, Yuichiro Matsuo, Masaaki Akahane, Daisuke Itoh, Osamu Abe","doi":"10.1016/j.jvir.2025.09.021","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.09.021","url":null,"abstract":"<p><strong>Purpose: </strong>Preventive transarterial embolization (TAE) for splenic artery aneurysm (SAA) is recommended in high-risk cases owing to the high mortality after rupture. This study evaluated the cost-effectiveness of preventive TAE for SAAs smaller than guideline-recommended threshold of 30 mm.</p><p><strong>Materials and methods: </strong>A Markov model with six states (well without treatment, well after treatment, TAE for aneurysm growth, recanalization, rupture, and death) was developed to compare preventive TAE with the watch-and-wait strategy using 1-year cycles over a lifetime. Model parameters were derived from prior studies and a national administrative claims database in Japan. The base case was a 60-year-old female with SAA measuring 20 mm. The incremental cost-effectiveness ratio (ICER) was evaluated against Japan's willingness-to-pay threshold of 5 million yen per quality-adjusted life year (QALY). Deterministic and probabilistic sensitivity analyses incorporated scenarios varying multiple parameters.</p><p><strong>Results: </strong>Analysis of 2,870 patients undergoing preventive TAE for SAAs from the database revealed an ICER of 3,522,204 yen/QALY (22,724 USD/QALY) in the base case, below the threshold. The ICER exceeded the threshold at 71.4 years in females and 65.9 in males. Quality-of-Life (QOL) improvement by treatment (12 to 24 months and longer), time to QOL difference resolution, age at discovery and costs of preventive TAE were the key ICER influencers. Without QOL improvement, preventive TAE was not cost-effective.</p><p><strong>Conclusion: </strong>Preventive TAE for SAA may be cost-effective, but only when treatment leads to improvements in QOL. These findings highlight the importance of patient selection and can guide cost-conscious clinical decision-making and reimbursement policy.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}